Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00039312 · ClinicalTrials.gov registry record · NA
Comparison of Screening Tests in Detecting Cervical Neoplasia
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00039312 is a NA study that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 15 participants.
The verdict
NCT00039312, a NA study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
RATIONALE: Screening tests may help doctors detect abnormal cells in the cervix early and plan effective treatment. PURPOSE: Screening trial to compare different types of screening tests used to detect cervical neoplasia.
Interventions
- OTHER cytology specimen collection procedure
- PROCEDURE comparison of screening methods
- OTHER Papanicolaou test
- PROCEDURE colposcopic biopsy
- PROCEDURE annual screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 1999-12 |
| Est. Completion | 2010-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00039312
The ClinicalTrials.gov registry entry for NCT00039312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which cytology specimen collection procedure is the first listed.
NCT00039312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00039312 about?
NCT00039312 is a clinical study titled "Comparison of Screening Tests in Detecting Cervical Neoplasia". RATIONALE: Screening tests may help doctors detect abnormal cells in the cervix early and plan effective treatment. PURPOSE: Screening trial to compare different types of screening tests used to detect cervical neoplasia.
What is the current status of trial NCT00039312?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 1999-12. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00039312?
The interventions under investigation include: cytology specimen collection procedure (OTHER), comparison of screening methods (PROCEDURE), Papanicolaou test (OTHER), colposcopic biopsy (PROCEDURE), annual screening (PROCEDURE).
Who is sponsoring clinical trial NCT00039312?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.